MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
133.70%
Quick Ratio
133.70%
Cash Ratio
68.63%
Debt to Asset Ratio
79.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable debt securities
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
18,855
5,766
15,422
8,919
Marketable debt securities
14,141
35,252
51,435
67,337
Restricted cash
1,472
1,472
1,472
1,472
Prepaid expenses and other current assets
2,266
3,082
3,776
5,345
Total current assets
36,734
45,572
72,105
83,073
Property and equipment gross
-
-
15,004
-
Less accumulated depreciation and amortization
-
-
7,007
-
Property and equipment, net
7,237
7,538
7,997
8,460
Intangible assets, net
-
-
0
2,434
Operating lease right-of-use asset
10,951
11,190
11,418
11,637
Total assets
54,922
64,300
91,520
105,604
Accounts payable
3,269
4,989
10,885
9,756
Private placement advance liability
10,000
-
-
-
Accrued expenses and other current liabilities
12,381
9,786
8,554
7,996
Operating lease liabilities, current portion
1,824
1,757
1,692
1,630
Total current liabilities
27,474
16,532
21,131
19,382
Operating lease liabilities, net of current portion
16,008
16,497
16,958
17,400
Financing lease liabilities, net of current portion
0
3
23
43
Total liabilities
43,482
33,032
38,112
36,825
Common stock, 0.001 par value per share 190,000,000 shares authorized 63,434,936 and 62,690,229 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
63
63
63
62
Additional paid-in capital
503,176
497,654
496,469
493,719
Accumulated other comprehensive (loss) income
-4
0
53
69
Accumulated deficit
-491,795
-466,449
-443,177
-425,071
Total stockholders' equity
11,440
31,268
53,408
68,779
Total liabilities and stockholders' equity
54,922
64,300
91,520
105,604
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$18,855K (75.67%↑ Y/Y)Marketable debt securities$14,141K (-81.92%↓ Y/Y)Prepaid expenses andother current assets$2,266K (-65.35%↓ Y/Y)Restricted cash$1,472K (0.00%↑ Y/Y)Total current assets$36,734K (-63.25%↓ Y/Y)Operating leaseright-of-use asset$10,951K (-7.56%↓ Y/Y)Property and equipment,net$7,237K (-18.90%↓ Y/Y)Total assets$54,922K (-55.43%↓ Y/Y)Total liabilities andstockholders' equity$54,922K (-55.43%↓ Y/Y)Total liabilities$43,482K (22.24%↑ Y/Y)Total stockholders'equity$11,440K (-86.95%↓ Y/Y)Accumulated deficit-$491,795K (-22.01%↓ Y/Y)Accumulated othercomprehensive (loss) income-$4K (20.00%↑ Y/Y)Total currentliabilities$27,474K (55.41%↑ Y/Y)Operating leaseliabilities, net of current...$16,008K (-10.23%↓ Y/Y)Additional paid-in capital$503,176K (2.55%↑ Y/Y)Common stock, 0.001 parvalue per share...$63K (1.61%↑ Y/Y)Accrued expenses andother current...$12,381K (84.85%↑ Y/Y)Private placementadvance liability$10,000K Accounts payable$3,269K (-65.27%↓ Y/Y)Operating leaseliabilities, current portion$1,824K (16.33%↑ Y/Y)

Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology, Inc. (PYXS)